Trusted Experts.
Strategic Minds.
Meet the thought leaders helping shape PanGIA Biotech’s vision for scalable, AI/ML-powered cancer diagnostics.
PanGIA Biotech’s Strategic Advisory Board brings deep expertise across oncology, diagnostics, bioinformatics, commercialization, and regulatory strategy.
These advisors provide insight, credibility, and forward momentum—helping us scale our platform, refine our science, and deliver meaningful results for patients and clinicians worldwide.
Kyle Ambert, Ph.D.
Strategic Advisor,Bioinformatics & AI
A recognized expert in biomedical informatics and computational biology, Dr. Ambert brings deep experience in AI, machine learning, and data infrastructure. His work at Intel, Nike, and OHSU has advanced predictive modeling, digital pathology, and biomolecular analytics.
At PanGIA, he guides AI strategy, bioinformatics development, and algorithmic precision to accelerate scalable diagnostics.
Caroline Popper, M.D., J.D.
Strategic Advisor, Commercialization & Market AccessDr. Popper is a seasoned healthcare executive with decades of experience in diagnostics, global strategy, and commercialization. As co-founder of Popper and Company, she has guided leading life science firms through regulatory approval, market adoption, and payer alignment.
At PanGIA, she supports industry partnerships, reimbursement strategy, and commercial scalability.